Cargando…

Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience

Nivolumab is an effective and safe treatment in HCC.

Detalles Bibliográficos
Autores principales:	Al jarroudi, Ouissam, Chaabouni, Hamed, Ulusakarya, Ayhan, Almohamad, Wathek, Gumus, Yusuf, Goldschmidt, Emma, Afqir, Said, Morère, Jean‐francois
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077298/ https://www.ncbi.nlm.nih.gov/pubmed/33936657 http://dx.doi.org/10.1002/ccr3.3970

Ejemplares similares

Anti-Programmed Cell Death Protein 1 (PD-1) Immunotherapy for Metastatic Hepatocellular Carcinoma After Liver Transplantation: A Report of Three Cases
por: Al Jarroudi, Ouissam, et al.
Publicado: (2020)

Patient-tailored FOLFIRINOX as first line treatment of patients with advanced pancreatic adenocarcinoma
por: Ulusakarya, Ayhan, et al.
Publicado: (2019)

Bevacizumab in metastatic colorectal cancer in a real-life setting – toxicity profile, survival outcomes, and impact of tumor sidedness
por: Chibani, Hind, et al.
Publicado: (2022)

A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer
por: Ulusakarya, Ayhan, et al.
Publicado: (2020)

Ovarian cancer in Morocco: Time to act is now
por: El Bairi, Khalid, et al.
Publicado: (2021)

Tracing ovarian cancer research in Morocco: A bibliometric analysis
por: El Bairi, Khalid, et al.
Publicado: (2021)

Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-Analyses
por: El Bairi, Khalid, et al.
Publicado: (2021)

Practical Tools and Guidelines for Young Oncologists From Resource-Limited Settings to Publish Excellence and Advance Their Career
por: El Bairi, Khalid, et al.
Publicado: (2021)

Métastase vésicale d'un adénocarcinome gastrique en bague à chaton
por: Seddik, Youssef, et al.
Publicado: (2014)

Overweight: Is It a Prognostic Factor in Women with Triple-Negative Breast Cancer?
por: Jarroudi, Ouissam Al, et al.
Publicado: (2017)

Unusual Metastasis From Breast Cancer: Case Report
por: Jaouani, Laila, et al.
Publicado: (2021)

Undifferentiated Sarcoma: A Rare Tumor of the Prostate
por: Jaouani, Laila, et al.
Publicado: (2023)

Very late recurrence of Diethylstilbestrol - related clear cell carcinoma of the cervix: case report
por: Adani-Ifè, Ablavi, et al.
Publicado: (2015)

An Extranodal Site of Diffuse Large B-cell Lymphoma Presenting as Ovarian Cancer
por: Jaouani, Laila, et al.
Publicado: (2023)

An unusual presentation of ovarian carcinoma with supraclavicular lymph node and colorectal metastases leading to spontaneous rectovaginal fistula
por: Kharmach, Ikram, et al.
Publicado: (2023)

Serum procalcitonin as a tumor marker in lung adenocarcinoma with ovarian metastasis: a case report
por: Omari, Mouhsine, et al.
Publicado: (2023)

Unusual Synchronous Colonic Metastasis of Ovarian Cancer
por: Jaouani, Laila, et al.
Publicado: (2023)

Pharmacologic modulation of 5-fluorouracil by folinic acid and high-dose pyridoxine for treatment of patients with digestive tract carcinomas
por: Machover, David, et al.
Publicado: (2021)

Pharmacologic modulation of 5-fluorouracil by folinic acid and pyridoxine for treatment of patients with advanced breast carcinoma
por: Machover, David, et al.
Publicado: (2022)

Nottingham Prognostic Index is an Applicable Prognostic Tool in Non-Metastatic Triple-Negative Breast Cancer
por: jarroudi, O Al, et al.
Publicado: (2019)

Triple Negative Breast Cancer at the University Hospital Mohammed VI – Oujda
por: Al jarroudi, O, et al.
Publicado: (2017)

Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma
por: Legros, Laurence, et al.
Publicado: (2023)

Programmed Cell Death Protein‐1 (PD‐1)‐Targeted Immunotherapy for Advanced Hepatocellular Carcinoma in Real World
por: Cui, Hanzhi, et al.
Publicado: (2020)

COVID-19 real-world data for the US and lessons to reopen business
por: Goldschmidt-Clermont, Pascal J.
Publicado: (2020)

Real-World Use of Immunotherapy for Hepatocellular Carcinoma
por: Sara, Amir, et al.
Publicado: (2023)

Effectiveness and safety of lenvatinib plus anti‐programmed death‐1 antibodies in patients with hepatocellular carcinoma: A real‐world cohort study
por: Xu, Ming‐Hao, et al.
Publicado: (2023)

Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project
por: Innominato, Pasquale F, et al.
Publicado: (2016)

Early Prediction of Objective Response of Fibrinogen in a Real-World Cohort of Hepatocellular Carcinoma Cases Treated by Programmed Cell Death Receptor-1 and Lenvatinib
por: Shen, Yanjun, et al.
Publicado: (2021)

Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?
por: Wong, Linda L., et al.
Publicado: (2017)

Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2023)

Primary squamous cell carcinoma of the breast: a case report and review of literature
por: Seddik, Youssef, et al.
Publicado: (2015)

Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers
por: El Bairi, Khalid, et al.
Publicado: (2018)

Programmed cell death protein‐1 (PD‐1)‐targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real‐world cohort
por: Scheiner, Bernhard, et al.
Publicado: (2019)

Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
por: Wu, Wen-Chi, et al.
Publicado: (2022)

Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World Study
por: Chang, Xu, et al.
Publicado: (2023)

POSIX.4: programming for the real world
por: Gallmeister, Bill O
Publicado: (1995)

Vulvar melanoma: A diagnostic challenge for young women - a case report
por: Omari, Mouhsine, et al.
Publicado: (2022)

Hepatocellular Carcinoma Surveillance: Benefit of Serum Alfa-fetoprotein in Real-world Practice
por: Lersritwimanmaen, Patharapan, et al.
Publicado: (2018)

Sorafenib for the Treatment of Hepatocellular Carcinoma: A Single-centre Real-world Study
por: Hanzel, Jurij, et al.
Publicado: (2020)

A risk score based on real-world data to predict early death in acute promyelocytic leukemia
por: Österroos, Albin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0d9e52086tsdjrtlrlfsknvmje